Literature DB >> 7290870

Cognitive improvement associated with tricyclic antidepressant treatment of childhood major depressive illness.

R D Staton, H Wilson, R A Brumback.   

Abstract

11 children fulfilling DSM-III criteria for major depressive illness were administered detailed neuropsychological batteries prior to and 3 to 6 mo. after starting tricyclic antidepressant treatment. Remission of depressive illness in children with melancholic major depression was associated with significant improvement in WISC-R Verbal IQ and Performance IQ, and on the Similarities, Comprehension, Block Design, and Coding subtests. In addition, there were significant improvements on the Halstead Categories test, on the Visual Reception subtest of the Illinois Test of Psycholinguistic Abilities, and in response latencies on the Matching Familiar Figures test. Two children with evidence of mild left hemiparesis showed amelioration of hemiparesis during tricyclic antidepressant treatment.

Entities:  

Mesh:

Substances:

Year:  1981        PMID: 7290870     DOI: 10.2466/pms.1981.53.1.219

Source DB:  PubMed          Journal:  Percept Mot Skills        ISSN: 0031-5125


  4 in total

1.  Cognitive and personality function in myotonic muscular dystrophy.

Authors:  R A Brumback; H Wilson
Journal:  J Neurol Neurosurg Psychiatry       Date:  1984-08       Impact factor: 10.154

2.  Efficacy of antidepressants in child and adolescent depression: a meta-analytic study.

Authors:  K Papanikolaou; C Richardson; A Pehlivanidis; Z Papadopoulou-Daifoti
Journal:  J Neural Transm (Vienna)       Date:  2005-08-03       Impact factor: 3.575

Review 3.  The neuropsychology of depression: a literature review and preliminary model.

Authors:  Brian V Shenal; David W Harrison; Heath A Demaree
Journal:  Neuropsychol Rev       Date:  2003-03       Impact factor: 7.444

4.  No interaction between serotonin transporter gene (5-HTTLPR) polymorphism and adversity on depression among Japanese children and adolescents.

Authors:  Akemi Tomoda; Shota Nishitani; Naomi Matsuura; Takashi X Fujisawa; Junko Kawatani; Daiki Toyohisa; Mai Ono; Kazuyuki Shinohara
Journal:  BMC Psychiatry       Date:  2013-05-10       Impact factor: 3.630

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.